NEW YORK ( TheStreet) -- CHANGE IN RATINGSAllstate ( ALL) downgraded at UBS to Neutral from Buy, UBS said. $38 price target. Diminished upside for EPS. Ansys ( ANSS) upgraded at Baird from Market Perform to Outperform, Robert Baird said. $76 price target. Company is a clear market leader and can continue to gain market share. Becton Dickinson ( BDX) downgraded at Leerink to Market Perform, Leerink Swann said. Valuation call, based on an $80 price target. Cigna ( CI) upgraded at BMO from Market Perform to Outperform, BMO Capital said. $55 price target. Earnings power should improve in the coming quarters. Concur ( CNQR) downgraded at Goldman from Neutral to Sell, Goldman Sachs said. Valuation call, as the stock is up 51% over the past year. $56 price target. Jack in the Box ( JACK) downgraded at Lazard from Buy to Neutral, Lazard said. Valuation call, as the stock is up 25% year-to-date. Nordstrom ( JWN) downgraded at Baird from Outperform to Neutral, Robert Baird said. Valuation call, based on a $59 price target. Molycorp ( MCP) downgraded at JPMorgan from Neutral to Underweight, JP Morgan said. $11.50 price target. Company is facing a potential funding shortfall. MercadoLibre ( MELI) upgraded at JP Morgan from Neutral to Overweight, JP Morgan said. $100 price target. Company is leveraged to increased e-commerce adoption across Latin America. Annaly Capital ( NLY) downgraded at Wunderlich from Buy to Hold, Wunderlich said. $18 price target. Company could see higher prepayments in the near term. OpenTable ( OPEN) upgraded at Oppenheimer to Outperform from Perform, Oppenheimer said. $46 price target. Greater chance of positive catalysts. Palo Alto ( PANW) rated new Outperform at William Blair. Company can gain market share in the firewall upgrade cycle. Ralcorp Holdings ( RAH) upgraded at UBS to Buy from Neutral, UBS said. $75 price target. Pullback and better FY13 means stock upside. Sempra Energy ( SE) downgraded at Deutsche from Buy to Hold, Deutsche Bank said. $30 price target. Estimates also slashed, given commodity exposure. Steris ( STE) upgraded at JMP from Market Perform to Outperform, JMP Securities said. $38 price target. Company appears to be at the beginning of a multi-year margin expansion story.